Maxcyte (MXCT) FCF Margin (2020 - 2025)
Maxcyte (MXCT) has disclosed FCF Margin for 6 consecutive years, with 135.78% as the latest value for Q3 2025.
- On a quarterly basis, FCF Margin fell 3216.0% to 135.78% in Q3 2025 year-over-year; TTM through Sep 2025 was 207.42%, a 12784.0% decrease, with the full-year FY2024 number at 131.72%, down 151.0% from a year prior.
- FCF Margin was 135.78% for Q3 2025 at Maxcyte, down from 122.68% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 56.98% in Q3 2022 to a low of 2691.89% in Q4 2024.
- A 5-year average of 244.81% and a median of 99.82% in 2023 define the central range for FCF Margin.
- Peak YoY movement for FCF Margin: skyrocketed 30752bps in 2023, then tumbled -269328bps in 2024.
- Maxcyte's FCF Margin stood at 14.34% in 2021, then tumbled by -2235bps to 306.13% in 2022, then skyrocketed by 100bps to 1.39% in 2023, then plummeted by -194043bps to 2691.89% in 2024, then soared by 95bps to 135.78% in 2025.
- Per Business Quant, the three most recent readings for MXCT's FCF Margin are 135.78% (Q3 2025), 122.68% (Q2 2025), and 262.3% (Q1 2025).